The Board of Trustees of the United States Pharmacopeial Convention (USP) today announced that Ron Piervincenzi will become the chief executive officer of USP and chair of USP’s standards-setting body, the Council of Experts. Piervincenzi will assume these responsibilities Feb. 1, 2014.

“I am excited and honored to lead USP’s mission to improve global health,” said Piervincenzi. “This is an outstanding organization doing life-changing work around the world, and I look forward to focusing the collective energy, expertise and knowledge of USP’s global volunteers and staff on the challenges of the future.”

“In Dr. Piervincenzi we have found an outstanding new leader for USP, which has seen unprecedented growth over the past several years,” said USP Board of Trustees Chair, Thomas R. Temple, R.Ph., M.S. “I am excited about Dr. Piervincenzi’s commitment to the next phase of USP’s unique mission to develop and promote cutting edge global standards for pharmaceuticals, food, and dietary supplements.”

Piervincenzi was a partner and leader in McKinsey & Company's Global Pharmaceutical and Medical Products Practice for 12 years where, among other responsibilities, he launched McKinsey's global drug safety, medical and regulatory service line.  Dr. Piervincenzi earned an MS and PhD from Duke University in Biomedical Engineering with research focused on protein engineering.

PharmTech News

Ron Piervincenzi to assume leadership of the United States Pharmacopeial Convention on Feb. 1, 2014.